Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
April 17, 2018
Patent Application Number
15016841
Date Filed
February 5, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
